2013 CPhI Pharma Awards Now Open

CPhI Worldwide, organised by UBM Live, is calling for entries to the annual CPhI Pharma Awards as it celebrates its 10th consecutive year. Open to the entire pharma industry for the first time, the awards honour pharma innovators across three categories—formulation, process development and packaging—with one winner for each award. The winners will be announced on 22nd October during the CPhI Worldwide 2013 exhibition at the Messe Frankfurt.

Andrew Pert, Pharma Brand Director, noted that the CPhI Pharma Awards present an ideal opportunity to share exciting, breakthrough innovations to the pharmaceutical industry. “We are proud to be entering our 10th year of running the awards to acknowledge and recognise the sheer determination and efforts that companies pour into their work,” said Pert. “Not only do companies receive the recognition that they deserve for their outstanding innovations, but entry into the Pharma Awards also gives unrivalled exposure to the media, whilst raising company profiles amongst key pharmaceutical industry professionals and VIPs.”

Last year at the Feria de Madrid in Spain, Haemopharm Healthcare won the gold award in the Best Innovation category for their needle free vial closure- designed to connect a syringe and vial without any further components; the innovative needle-free system facilitated an easier administration of parenteral drugs. Merck Millipore took silver for their drug delivery platform using silica, which takes full advantage of the large surface area and good transport properties that silica possesses. The bronze award went to Bioclin for its Multi-Oral Remin remineralization gel, applied in the oral cavity to treat and prevent bleeding gums and tooth erosion.

CPhI is now accepting applications for the 2013 CPhI Pharma Awards until Friday 26th July. Entries are open to individuals and companies who have developed innovations in pharma over the past year. For more information, or to submit an award entry, please visit www.cphi.com/pharma-awards.